| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |